The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2025
Filed:
Nov. 01, 2024
Applicant:
Neurotech Usa, Inc., Cumberland, RI (US);
Inventors:
Jeffrey Louis Goldberg, San Diego, CA (US);
Cahil Mcgovern, North Kingstown, RI (US);
Weng Tao, Lincoln, RI (US);
Konrad A. Kauper, Sutton, MA (US);
Assignee:
Neurotech USA, Inc., Cumberland, RI (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61F 9/00 (2006.01); A61K 9/48 (2006.01); A61K 35/30 (2015.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61F 9/0017 (2013.01); A61K 9/4816 (2013.01); A61K 35/30 (2013.01); A61K 38/185 (2013.01); A61K 38/19 (2013.01); A61K 38/2066 (2013.01); A61K 38/212 (2013.01); A61K 38/215 (2013.01);
Abstract
Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.